NIAID Site Search

Last Reviewed: March 19, 2025

This infographic details three easy steps to help researchers share their COVID-19 data.

Last Reviewed: May 7, 2020

This infographic details three easy steps to help researchers share their COVID-19 data.

Last Reviewed: March 30, 2020

This infographic provides an overview of different long-acting forms of HIV prevention.

Last Reviewed: July 11, 2019

NIAID offers a comprehensive suite of resources and services that address gaps along the infectious diseases product development pathway. These services assist in the development of the next generation of vaccines, diagnostics, and therapeutics for a broad array of bacterial, viral, fungal, and parasitic pathogens. Eligible investigators worldwide can get access to expertise, research materials

Last Reviewed: July 15, 2024

An infographic from NIAID which depicts the progress that has been made towards an HIV vaccine

Last Reviewed: May 17, 2018

You may download a PDF of the infographic for a full description or printing. To print, after downloading the PDF, select “fit to page” in printer settings. Larger paper sizes will yield best results. For web posting, the NIAID Flickr site offers a high-resolution JPEG.

Last Reviewed: July 11, 2019

This poster provides information about the progress that has been made in developing a safe, effective, and preventive HIV vaccine.

Last Reviewed: May 17, 2018

An ancillary study is an independent research project that uses samples or data from a parent study to extend knowledge in scientific areas beyond the original scope of the parent study. It may qualify as a clinical study or a clinical trial.

Published: June 20, 2024

Note: This image may be downloaded from the NIAID Flickr site.

Last Reviewed: June 19, 2018

Information about NIAID’s efforts to support research of passive antibody transfer for HIV prevention.

Last Reviewed: October 25, 2018

NIAID offers a comprehensive suite of resources and services that address gaps along the product development pathway. These services assist in the development of the next generation of vaccines, diagnostics, and therapeutics for a broad array of bacterial, viral, fungal, and parasitic pathogens. Eligible investigators worldwide can get access to expertise, research materials, and state-of-the-art

Last Reviewed: November 13, 2024

To be eligible, you must be a doctoral-level clinician or researcher who’s committed to conducting NIH-qualified clinical research. If NIH approves your application, we will repay up to $50,000 each year toward your qualified educational debt.

Published: August 7, 2024

Background information about the Pre-exposure Prophylaxis (PrEP) strategy to reduce HIV risk and past studies from NIAID

Last Reviewed: September 13, 2024

Background information about the history of antiretroviral drug discovery and development which highlights major advancements from NIAID.

Last Reviewed: February 5, 2024

NIAID-supported research has contributed to great increases in the number and efficacy of autoimmune disease treatment approaches available. Even so, unmet needs remain. These include: Immune therapies that are less toxic and create less risk of infection. Precision approaches for selecting the right therapy for each person with autoimmune disease. Treatment options for people who don’t respond to

Last Reviewed: March 21, 2025

With Gratitude to Dr. Hugh Auchincloss, and a Welcome to Dr. Sarah Read; Newcomer to NIH Funding? Attend the NIH Grants Process Primer Webinar; OLAW Annual Reports Are Due on December 1; Loan Repayment Program Application Deadline Is November 21

Published: October 16, 2024

Information about available services, eligibility, product evaluation criteria, and the request process are unique to each program. DMID scientific contacts are listed for each resource and are available to answer questions and provide further guidance about access to these resources. In Vitro Assessments of Antimicrobial Activity. These services evaluate promising candidate countermeasures in

Last Reviewed: April 8, 2025

An overview of sustained antiretroviral therapy (ART) and alternative ART-Free options for HIV remission from NIAID.

Last Reviewed: October 18, 2018

Information about the importance of starting and staying on antiretroviral treatment for HIV management from NIAID.

Last Reviewed: November 27, 2018

Learn how to interpret your NIH summary statement for information about the review, the reviewers’ critiques, and your score.

Last Reviewed: January 8, 2025

NIAID's ability to plan funding opportunities for extramural researchers ties into the budget planning cycle for each fiscal year.

Last Reviewed: May 18, 2022